Skip to content

Efficacy of Topical Tranexamic Acid on Operative Bleeding in Endoscopic Endonasal Dacryocystorhinostomy: A Multi Center, Double masked, Prospective, Randomized Clinical Trial

Efficacy of Topical Tranexamic Acid on Operative Bleeding in Endoscopic Endonasal Dacryocystorhinostomy: A Multi Center, Double masked, Prospective, Randomized Clinical Trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500106517
Enrollment
Unknown
Registered
2025-07-24
Start date
2025-08-15
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eye and adnexa

Interventions

Intervention Group:Neuropatty soaked with 20mL of TXA 1000mg/10mL preparation applied for 2 minutes
Control Group:Neuropatty soaked with 20ml Normal Saline Solution (NSS) applied for 2 minutes

Sponsors

Department of Ophthalmology and Visual Sciences (DOVS), The Chinese University of Hong Kong
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients aged = 18 years old, male or female. 2. Patients diagnosed with Primary Acquired Naso Lacrimal Duct Obstruction (NLDO) 3. Patients advised to undergo Endoscopic Endonasal Dacryocystorhinostomy (EEDCR)

Exclusion criteria

Exclusion criteria: 1. Bleeding tendency including hematological disease (thrombocytopenia, hemophilia, clotting disorders) 2. Patients with co-morbidities like uncontrolled hypertension, malignant hyperthermia, acute or chronic renal failure, and familial history of blood dyscrasia. 3. Concomitant sinonasal pathologies requiring additional procedures e.g., septoplasty, turbinoplasty 4. History of previous lacrimal surgery or any endonasal surgeries 5. Secondary causes of nasolacrimal duct obstruction such as previous irradiation, trauma-related bony deformities or laceration to lacrimal passages, systemic chemotherapy, major diseases affective the respective side of nose and orbit 6. Pregnant or breast-feeding patients.

Design outcomes

Primary

MeasureTime frame
Intraoperative Blood loss;Intraoperative Blood loss;

Secondary

MeasureTime frame
Mean Arterial Pressure, Diastolic Blood Pressure, Systolic Blood Pressure and Heart rate, at 15-minute mark;Recurrence of bleeding after removal nasal packing on post-operative day 1.;1-day post-operative laboratory investigations like bleeding and clotting factors.;Weight of ribbon gauze used for post-operation nasal packing;

Countries

China

Contacts

Public ContactDr CHONG Kam Lung Kelvin

Department of Ophthalmology and Visual Sciences

chongkamlung@cuhk.edu.hk+852 3943 5805

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026